The Public Health Agency has supported Council for the Homeless NI to produce harm reduction booklets on NPS. These booklets are NOT aimed at the general population, but are specifically aimed at adults who are already taking either stimulant-type drugs, or synthetic cannabinoids (“herbal”). They give basic information and advice on how to reduce the risks of taking these substances.

Regional Joint Service Agreement protocol for Hidden Harm.

This Infant Mental Health Framework represents a commitment by the Public Health Agency, Health and Social Care Board and Trusts, as well as academic, research, voluntary and community organisations across Northern Ireland, to improve interventions from the ante-natal period through to children aged three years old.

This Business Plan sets out the key priorities and actions that will be progressed by the Public Health Agency (PHA) in 2016/17. The PHA believes that these actions will have the biggest impact on improving levels of health and social wellbeing, protecting the health of the community, and ensuring patients continue to receive high quality and safe treatment and care services.

The business plan is available to download below.

Regional report of experience of nursing and midwifery care key performance indicators.

Patient and Client Experience Standards Biennial Report April 2013 toMarch 2015

This report presents the analysis of the information which has been received during Phase 2 of 10,000 Voices (February 2014 –September 2015) from patients/clients/carers and family members who receive care in their own homes.

This poster was produced for the smoking cessation public information campaign with the message that 1 in 2 smokers will die from tobacco-related disease.

An abdominal aortic aneurysm (AAA) is a swelling in the abdominal aorta, which is the main artery that supplies blood to your body. As the AAA grows, the wall of the aorta stretches and becomes weaker, which can eventually lead to a significant risk of a ruptured AAA. This is often fatal. The aim of the AAA screening programme is to reduce AAA-related mortality by providing a systematic, population-based screening programme.